Procurement Summary
Country : USA
Summary : Notice of Intent to Sole Source to Bio Fire Defense Llc
Deadline : 03 May 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 100371670
Document Ref. No. : 24-005700
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Purchaser : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Contracting Office Address : BETHESDA, MD 20892
Primary Point of Contact : Shasheshe Goolsby
shasheshe.goolsby@nih.gov
Phone Number 3018274879
USA
Email :shasheshe.goolsby@nih.gov
Tender Details
Description
Title
Bio Fire Reagent Kits for the Department of Laboratory Medicine at the NIH Clinical Center
Product Service Code: 6550 NAICS Code: 325413 Place of Performance:Bethesda, MD 20892 USA
POTS: 24-005700
Description
This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested.
The National Institutes of Health (NIH) intends to award a firm fixed price purchase order to Bio Fire Defense LLC of Salt Lake City, Utah 84107-2663.
The purpose of this acquisition is to procure testing kits from Bio Fire Defense LLC for the continued provision of clinical testing at the Clinical Center with existing instrumentation located within DLM. (i.e., Film Array Analyzers) These instruments provide rapid, efficient, and sensitive detection of nucleic acid (DNA) from clinical samples, which allows for timely identification of the presence of infectious agents and hastens treatment. The period of performance is from 05/13/2024 to 09/30/2024.
The below items are required for this action:
Description Product Code Quantity
Blood Culture Identification Panel 2 IVD, 30 Tests RFIT-ASY-0147 10
Gastrointestinal Panel IVD, 30 Tests RFIT-ASY-0116-GSA 20
Meningitis/Encephalitis Panel IVD, 30 Tests RFIT-ASY-0118-GSA 6
Respiratory Panel 2.1 IVD, 30 Tests 423742 40
The proposed vendor, Bio Fire Defense LLC of these reagent kits. Bio Fire Defense is the only vendor that can provide the specific test kits required for use with existing instrumentation and already established and validated lab tests.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the c...
Active Contract Opportunity Notice ID 24-005700 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH - CC
General Information
Contract Opportunity Type: Presolicitation (Original)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Original Published Date: Apr 22, 2024 12:21 pm EDT
Original Response Date: May 03, 2024 06:30 am EDT
Inactive Policy: Manual
Original Inactive Date: May 04, 2024
Initiative: None
Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
Place of Performance: Bethesda, MD 20892 USA
Documents
Tender Notice